Non‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma

Abstract In a nondiabetic patient, fasting hypoglycemia is uncommon and warrants careful assessment. Although rare, NICTH should be considered in patients with recurrent hypoglycemia especially in those with risk factors for HCC.

Guardado en:

Detalles Bibliográficos
Autores principales:	Imen Rojbi, Wiem Ben Elhaj, Nadia Mchirgui, Meriem Jrad, Ibtissem Ben Nacef, Karima Khiari
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	hepatocellular carcinoma hypoglycemia IGF‐2 NICTH Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/0057de252b584d0ba0aec3386aac37b5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0057de252b584d0ba0aec3386aac37b5
record_format	dspace
spelling	oai:doaj.org-article:0057de252b584d0ba0aec3386aac37b52021-12-02T07:55:57ZNon‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma2050-090410.1002/ccr3.5012https://doaj.org/article/0057de252b584d0ba0aec3386aac37b52021-10-01T00:00:00Zhttps://doi.org/10.1002/ccr3.5012https://doaj.org/toc/2050-0904Abstract In a nondiabetic patient, fasting hypoglycemia is uncommon and warrants careful assessment. Although rare, NICTH should be considered in patients with recurrent hypoglycemia especially in those with risk factors for HCC.Imen RojbiWiem Ben ElhajNadia MchirguiMeriem JradIbtissem Ben NacefKarima KhiariWileyarticlehepatocellular carcinomahypoglycemiaIGF‐2NICTHMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	hepatocellular carcinoma hypoglycemia IGF‐2 NICTH Medicine R Medicine (General) R5-920
spellingShingle	hepatocellular carcinoma hypoglycemia IGF‐2 NICTH Medicine R Medicine (General) R5-920 Imen Rojbi Wiem Ben Elhaj Nadia Mchirgui Meriem Jrad Ibtissem Ben Nacef Karima Khiari Non‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma
description	Abstract In a nondiabetic patient, fasting hypoglycemia is uncommon and warrants careful assessment. Although rare, NICTH should be considered in patients with recurrent hypoglycemia especially in those with risk factors for HCC.
format	article
author	Imen Rojbi Wiem Ben Elhaj Nadia Mchirgui Meriem Jrad Ibtissem Ben Nacef Karima Khiari
author_facet	Imen Rojbi Wiem Ben Elhaj Nadia Mchirgui Meriem Jrad Ibtissem Ben Nacef Karima Khiari
author_sort	Imen Rojbi
title	Non‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma
title_short	Non‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma
title_full	Non‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma
title_fullStr	Non‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma
title_full_unstemmed	Non‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma
title_sort	non‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/0057de252b584d0ba0aec3386aac37b5
work_keys_str_mv	AT imenrojbi nonisletcelltumorhypoglycemiaasfirstmanifestationofanadvancedhepatocellularcarcinoma AT wiembenelhaj nonisletcelltumorhypoglycemiaasfirstmanifestationofanadvancedhepatocellularcarcinoma AT nadiamchirgui nonisletcelltumorhypoglycemiaasfirstmanifestationofanadvancedhepatocellularcarcinoma AT meriemjrad nonisletcelltumorhypoglycemiaasfirstmanifestationofanadvancedhepatocellularcarcinoma AT ibtissembennacef nonisletcelltumorhypoglycemiaasfirstmanifestationofanadvancedhepatocellularcarcinoma AT karimakhiari nonisletcelltumorhypoglycemiaasfirstmanifestationofanadvancedhepatocellularcarcinoma
_version_	1718399081279127552

Non‐islet‐cell tumor hypoglycemia as first manifestation of an advanced hepatocellular carcinoma

Ejemplares similares